Guided Therapeutics Inc SEC filings GTHP
Guided Therapeutics Inc has 1,000 filings in SEC EDGAR's recent list, going back to Apr 14, 2004. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Mar 10, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Jul 6, 2021 | Jul 2, 2021 |
| PRE 14A | Preliminary proxy statement | Jun 22, 2021 | Jun 22, 2021 |
| DEF 14A | Proxy statement | Oct 11, 2018 | Oct 10, 2018 |
| PRE 14A | Preliminary proxy statement | Sep 28, 2018 | Sep 28, 2018 |
| DEF 14A | Proxy statement | Sep 17, 2018 | Sep 17, 2018 |
| PRE 14A | Preliminary proxy statement | Sep 5, 2018 | Sep 5, 2018 |
| DEFA14A | Additional proxy material | Aug 26, 2016 | — |
| DEF 14A | Proxy statement | Aug 25, 2016 | Aug 25, 2016 |
| PRE 14A | Preliminary proxy statement | Aug 12, 2016 | Aug 12, 2016 |
| PRE 14A | Preliminary proxy statement | Aug 3, 2016 | Aug 3, 2016 |
| PRE 14A | Preliminary proxy statement | Jul 7, 2016 | Jul 7, 2016 |
| PRE 14A | Preliminary proxy statement | Jun 15, 2016 | Jun 15, 2016 |
| DEF 14A | Proxy statement | Oct 14, 2015 | Oct 14, 2015 |
| PRE 14A | Preliminary proxy statement | Oct 2, 2015 | Oct 2, 2015 |
| DEF 14A | Proxy statement | Jul 31, 2015 | Jul 31, 2015 |
| PRE 14A | Preliminary proxy statement | Jul 20, 2015 | Jul 17, 2015 |
| DEF 14A | Proxy statement | Apr 27, 2015 | Apr 27, 2015 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2015 | Apr 13, 2015 |
| DEF 14A | Proxy statement | May 13, 2014 | May 13, 2014 |
| PRE 14A | Preliminary proxy statement | May 2, 2014 | May 2, 2014 |
| DEF 14A | Proxy statement | Apr 26, 2013 | Apr 26, 2013 |
| DEF 14A | Proxy statement | Apr 30, 2012 | Apr 30, 2012 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2012 | Apr 17, 2012 |
| DEF 14A | Proxy statement | Jun 30, 2011 | Jun 28, 2011 |
| DEF 14A | Proxy statement | Apr 20, 2010 | Apr 20, 2010 |
| DEF 14A | Proxy statement | Feb 3, 2010 | Feb 3, 2010 |
| PRE 14A | Preliminary proxy statement | Oct 14, 2009 | Oct 14, 2009 |
| DEF 14A | Proxy statement | Nov 19, 2008 | Dec 31, 2007 |
| DEF 14A | Proxy statement | Sep 25, 2007 | Sep 25, 2007 |
| DEF 14A | Proxy statement | May 1, 2006 | May 1, 2006 |
| DEF 14A | Proxy statement | May 10, 2005 | May 10, 2005 |
| DEF 14A | Proxy statement | Apr 23, 2004 | Apr 23, 2004 |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- GTHP (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Peachtree Corners, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 924515
- Former names
- SPECTRX INC (until Feb 28, 2008)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.